Table 1.

Baseline characteristics of the subjects

	Febuxostat n = 105	Benzbromarone n = 109	P value
Age, years	52.42 ± 11.73	50.27 ± 14.15	0.23
Onset age, years	41.80 ± 10.57	43.19 ± 13.15	0.48
Height, cm	172.65 ± 5.65	172.39 ± 5.83	0.77
Body weight, kg	78.89 ± 9.49	77.27 ± 9.55	0.28
BMI, kg/m2	26.59 ± 3.03	26.10 ± 2.75	0.25
Waistline, cm	94.60 ± 7.41	92.31 ± 7.92	0.10
Waist-to-hip ratio	0.92 ± 0.05	0.92 ± 0.04	0.65
Systolic BP, mmHg	128.42 ± 13.55	126.78 ± 16.93	0.51
Diastolic BP, mmHg	83.47 ± 8.74	82.07 ± 9.67	0.32
Coexisting conditions
Hypertension	25 (22.9)	20 (19.0)	0.33
Cardiovascular disease	5 (4.6)	7 (6.7)	0.60
Diabetes	7 (6.4)	3 (2.9)	0.30
Hyperlipidemia	32 (29.4)	34 (32.4)	0.91
Fatty liver	26 (23.9)	28 (26.7)	0.88
Tophus	26 (23.9)	21 (20)	0.33
Family history of gout	24 (22.0)	26 (24.8)	0.86

Data given as mean ± SD or number (%). *P ≤ 0.05. **P ≤ 0.01. BMI body mass index, BP blood pressure